陶瓷头模块化双动全髋关节置换术后血清钴水平普遍较低:高危患者的前瞻性研究
前瞻性纳入24例使用模块化双动构造与陶瓷股骨头的翻修或复杂初次全髋关节置换患者,平均随访4年,最近随访平均血清钴0.30 μg/l、铬0.76 μg/l,无患者钴≥1 μg/l,仅1例铬≥1 μg/l。作者支持在高脫位风险患者中选择性使用该构造,但需进一步研究。
要点
- 24例模块化双动全髋关节置换患者中,最近随访平均血清钴0.30 μg/l、铬0.76 μg/l。
- 无患者血清钴≥1 μg/l,仅1例血清铬≥1 μg/l(12 μg/l,翻修后57个月)。
- 7例因金属不良反应(ALTR)翻修者术前平均钴29.7 μg/l、铬21.5 μg/l,随访铬较术前下降十倍。
核心结论
- 平均随访4年时,使用模块化双动构造与陶瓷股骨头的患者无血清钴水平升高,包括7例因ALTR翻修者。
- 作者支持在高脫位风险的翻修和复杂初次全髋关节置换患者中选择性使用模块化双动构造,同时指出需进一步研究。
研究设计与样本
- 前瞻性研究,纳入24例使用模块化双动构造与陶瓷股骨头的翻修或复杂初次全髋关节置换患者。
- 排除使用钴铬(CoCr)股骨头或对侧全髋关节置换使用CoCr股骨头的患者。
- 平均年龄63岁(范围35至83岁),女性13例(54%),平均随访4年(范围2至7年)。
主要发现
- 模块化双动构造的适应证为:两阶段交换后再置入治疗的假体周围关节感染(n=8)、ALTR翻修(n=7)、复杂初次全髋关节置换(n=7)、复发性不稳(n=1)、假体周围股骨骨折(n=1)。
- 因ALTR翻修者术前平均血清钴29.7 μg/l(范围2至146)、铬21.5 μg/l(范围1至113)。
- 最近随访平均血清钴0.30 μg/l、铬0.76 μg/l。
- 无患者血清钴≥1 μg/l;仅1例血清铬≥1 μg/l,该例为因ALTR翻修后57个月血清铬12 μg/l,较术前铬113 μg/l下降十倍。
临床怎么用
- 作者支持在高脫位风险的翻修和复杂初次全髋关节置换患者中选择性使用模块化双动构造。
局限性
- 原文结论指出需进一步研究(further studies are required)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Modular dual-mobility constructs reduce the risk of dislocation after revision total hip arthroplasty (THA). However, questions about metal ions from the cobalt-chromium (CoCr) liner persist, and are particularly germane to patients being revised for adverse local tissue reactions (ALTR) to metal. We determined the early- to mid-term serum Co and Cr levels after modular dual-mobility components were used in revision and complex primary THAs, and specifically included patients revised for ALTR. PATIENTS AND METHODS: Serum Co and Cr levels were measured prospectively in 24 patients with a modular dual-mobility construct and a ceramic femoral head. Patients with CoCr heads or contralateral THAs with CoCr heads were excluded. The mean age was 63 years (35 to 83), with 13 patients (54%) being female. The mean follow-up was four years (2 to 7). Indications for modular dual-mobility were prosthetic joint infection treated with two-stage exchange and subsequent reimplantation (n = 8), ALTR revision (n = 7), complex primary THA (n = 7), recurrent instability (n = 1), and periprosthetic femoral fracture (n = 1). The mean preoperative Co and Cr in patients revised for an ALTR were 29.7 μg/l (2 to 146) and 21.5 μg/l (1 to 113), respectively. RESULTS: Mean Co and Cr levels were 0.30 μg/l and 0.76 μg/l, respectively, at the most recent follow-up. No patient had a Co level ≥ 1 μg/l. Only one patient had a Cr level ≥ 1 μg/l. That patient's Cr level was 12 μg/l at 57 months after revision THA for ALTR (and decreased ten-fold from a preoperative Cr of 113 μg/l). CONCLUSION: At a mean of four years, no patient with a modular dual-mobility construct and ceramic femoral head had elevated Co levels, including seven patients revised specifically for ALTR. While further studies are required, we support the selective use of a modular dual-mobility construct in revision and complex primary THAs for patients at high risk for instability. Cite this article: Bone Joint J 2019;101-B(6 Supple B):57-61.
引用
- Chalmers BP, Mangold DG, Hanssen AD, et al. Uniformly low serum cobalt levels after modular dual-mobility total hip arthroplasties with ceramic heads: a prospective study in high-risk patients. Bone Joint J. 2019. PMID: 31146553. doi:10.1302/0301-620X.101B6.BJJ-2018-1403.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。